DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zarontin (Ethosuximide) - Summary

 
 



ZARONTIN SUMMARY

Zarontin (ethosuximide) is an anticonvulsant succinimide, chemically designated as alpha-ethyl-alpha-methyl-succinimide.

Zarontin is indicated for the control of absence (petit mal) epilepsy.


See all Zarontin indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Zarontin (Ethosuximide)

Epilepsy at the molecular level
Source: Epilepsy News From Medical News Today [2016.02.11]
Researchers study the link between malformations of the cerebral cortex and the occurrence of the neurological disease.

Nerve damage in MS could be prevented with epilepsy drug
Source: Clinical Trials / Drug Trials News From Medical News Today [2016.01.26]
An epilepsy drug - phenytoin - reduced nerve damage by 30% in people with optic neuritis, a new study found, bringing us closer to a neuroprotective drug for multiple sclerosis.

Socio-economic status may impact care of children with epilepsy
Source: Epilepsy News From Medical News Today [2016.01.20]
Socio-economic status may influence the use of health resources among children with epilepsy, even in a universal health insurance system.

UCB's new epilepsy drug BRIVIACT receives EU approval
Source: Epilepsy News From Medical News Today [2016.01.20]
UCB have announced the European Commission (EC) has approved BRIVIACT® (brivaracetam) as an adjunctive therapy in the treatment of partial-onset seizures with or without secondary...

Epilepsy and marijuana: could cannabidiol reduce seizures?
Source: Epilepsy News From Medical News Today [2015.12.30]
A newly published study reveals that CBD reduces seizure frequency for children and young adults with epilepsy, offering hope for the over 5 million Americans with the condition.

more news >>

Published Studies Related to Zarontin (Ethosuximide)

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. [2010.03.04]
BACKGROUND: Childhood absence epilepsy, the most common pediatric epilepsy syndrome, is usually treated with ethosuximide, valproic acid, or lamotrigine. The most efficacious and tolerable initial empirical treatment has not been defined... CONCLUSIONS: Ethosuximide and valproic acid are more effective than lamotrigine in the treatment of childhood absence epilepsy. Ethosuximide is associated with fewer adverse attentional effects. (ClinicalTrials.gov number, NCT00088452.) 2010 Massachusetts Medical Society

Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges. [2011.07]
PURPOSE: Generalized absence seizures are characterized by bilateral spike-wave discharges (SWDs), particularly in the frontoparietal cortical region. In WAG/Rij and GAERS rats with absence epilepsy, recent evidence indicates that SWDs arise first from the lateral somatosensory cortex (LSC), that is, the cortical focus theory...

Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. [2010.08]
PURPOSE: Epilepsy is a heterogeneous syndrome characterized by recurrent, spontaneous seizures; continuous medication is, therefore, necessary, even after the seizures have long been suppressed with antiepileptic drug (AED) treatments. The most disturbing issue is the inability of AEDs to provide a persistent cure, because these compounds generally suppress the occurrence of epileptic seizures without necessarily having antiepileptogenic properties...

Ethosuximide converts ictogenic neurons initiating absence seizures into normal neurons in a genetic model. [2009.07]
Absence epilepsy is a form of generalized epilepsy commonly seen in children. The neuronal process by which ethosuximide (ETX), a first choice anti-absence drug, prevents absence seizures is still unresolved...

Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves. [2008.11]
The aim of this study was to characterize the interaction between tiagabine (TGB) and ethosuximide (ETS), two antiepileptic drugs, in pentylenetetrazole (PTZ)-induced clonic seizures in mice using isobolographic analysis. The nature of the interaction between the drugs administered in combination was ascertained by estimating plasma and brain concentrations of ETS and TGB using fluorescence polarization immunoassay (FPIA) and high-performance liquid chromatography (HPLC)...

more studies >>

Reports of Suspected Zarontin (Ethosuximide) Side Effects

Convulsion (4)Drug Ineffective (3)Poor Quality Drug Administered (3)Atelectasis (2)Pyrexia (2)Mycoplasma Infection (2)Abdominal Discomfort (2)Stevens-Johnson Syndrome (2)Oral Infection (2)Toxic Epidermal Necrolysis (2)more >>


Page last updated: 2016-02-11

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015